Your browser doesn't support javascript.
loading
HIV continuum of care: bridging cross-sectional and longitudinal analyses.
Touloumi, Giota; Thomadakis, Christos; Pantazis, Nikos; Papastamopoulos, Vasileios; Paparizos, Vasilios; Metallidis, Simeon; Adamis, Georgios; Chini, Maria; Psichogiou, Mina; Chrysos, Georgios; Sambatakou, Helen; Barbunakis, Emmanouil; Vourli, Georgia; Antoniadou, Anastasia.
  • Touloumi G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens.
  • Thomadakis C; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens.
  • Pantazis N; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens.
  • Papastamopoulos V; 5th Department of Internal Medicine - Division of Infectious Diseases, Evangelismos General Hospital of Athens.
  • Paparizos V; AIDS Unit, Clinic of Venereologic & Dermatologic Diseases, Medical School, National and Kapodistrian University of Athens, Syngros Hospital, Athens.
  • Metallidis S; 1 Internal Medicine Department, Infectious Diseases Unit, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki.
  • Adamis G; 1st Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens G. Gennimatas.
  • Chini M; 3rd Department of Internal Medicine - Infectious Diseases Unit, Red Cross General Hospital.
  • Psichogiou M; 1st Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens.
  • Chrysos G; Infectious Diseases Unit, Tzaneion General Hospital of Piraeus.
  • Sambatakou H; HIV Unit, 2nd Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Hippokration University General Hospital, Athens.
  • Barbunakis E; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete.
  • Vourli G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens.
  • Antoniadou A; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, Athens, Greece.
AIDS ; 36(4): 583-591, 2022 03 15.
Article en En | MEDLINE | ID: mdl-34772850
OBJECTIVE: The aim of this study was to propose a unified continuum-of-care (CoC) analysis combining cross-sectional and longitudinal elements, incorporating time spent between stages. DESIGN: The established 90-90-90 target follows a cross-sectional four-stage CoC analysis, lacking information on timing of diagnosis, antiretroviral therapy (ART) initiation, and viral suppression durability. METHODS: Data were derived from the Athens Multicenter AIDS Cohort Study (AMACS). In the cross-sectional CoC, we added stratification of diagnosed people with HIV (PWH) by estimated time from infection to diagnosis; of those who ever initiated ART or achieved viral suppression by corresponding current status (in 2018); and cumulative incidence function (CIF) of ART initiation and viral suppression, treating loss-to-follow-up (LTFU) as competing event. Viral suppression was defined as viral load less than 500 copies/ml. Viral suppression durability was assessed by the CIF of viral load rebound. FINDINGS: About 89.1% of PWH in 2018 were diagnosed (range of diagnoses: 1980-2018). Median time to diagnosis was 3.5 years (IQR: 1.1-7.0). Among diagnosed, 89.1% were ever treated, of whom 86.7% remained on ART. CIF of ART initiation and LTFU before ART initiation were 80.9 and 6.0% at 5 years since diagnosis, respectively. Among treated, 89.4% achieved viral suppression, of whom 87.4% were currently virally suppressed. The CIF of viral load rebound was 24.2% at 5 years since first viral suppression but substantially reduced in more recent years. INTERPRETATION: The proposed analysis highlights time gaps in CoC not evident by the standard cross-sectional approach. Our analysis highlights the need for early diagnosis and identifies late presenters as a key population for interventions that could decrease gaps in the CoC.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article